Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy

Transplant Proc. 1999 Sep;31(6):2515-6. doi: 10.1016/s0041-1345(99)00442-x.
No abstract available

MeSH terms

  • Azathioprine / therapeutic use
  • Cardiomyopathy, Dilated / surgery
  • Coronary Disease / surgery
  • Cyclosporine / adverse effects*
  • Female
  • Graft Rejection / drug therapy
  • Graft Rejection / prevention & control
  • Heart Transplantation / immunology*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney / drug effects
  • Kidney / pathology*
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Retrospective Studies

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Mycophenolic Acid
  • Azathioprine
  • Methylprednisolone